Cancer immunotherapy has historically focused on harnessing the ability of T cells to recognize and attack cancer cells. Adaptive immune checkpoint inhibitors (ICIs) unleash tumor-infiltrating ...
Feasibility Study for Using Large Language Models to Identify Goals-of-Care Documentation at Scale in Patients With Advanced Cancer A retrospective analysis of 3,626 patients treated with ICIs for ...
Over 315 patients screened and over 230 patients enrolled in BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint ...
MIRAMAR, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to ...
A retrospective study highlights the potential for encephalitis and other serious neurologic side effects over the course of ...
When immune checkpoint inhibitors are used in cancer treatment, in some cases it can lead to severe inflammation and damage to heart tissue. Histology images of mouse heart tissue illustrate the ...
Researchers conducted a multicenter observational study across three major US academic medical centers with registries of patients with rheumatic immune-related adverse events to assess the ...
BOSTON, June 13, 2025 — Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced ...
There was a widened disparity of 6.1 percentage points for 2-year overall survival rates increased post-ICI approval among uninsured individuals (16.2 to 28.3%) and those with private insurance (28.7 ...
Please provide your email address to receive an email when new articles are posted on . High-dose steroid use independently predicted hospital readmission for patients with immune checkpoint inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results